glp-1 dangers The promise and peril of agonists: What we do (and don't) know as of August 2024 SABCS 2025: Can GLP-1s Help

This piece covers the exact regulatory boundaries, what 'off-label' actually means in practice, and where enforcement actions have targeted specific glutathione products

Rotate injection sites (abdomen, thighs, upper arms) to help minimize irritation and support healthier tissue recovery

A good metric to consider is this: If an obese patient (BMI 30 to 34.9) is on a GLP-1 for six months and has not reached 10% TBWL, they should be referred back to their primary care provider to reassess their weight-loss plan

Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis

R., Sun S

FOXO4-DRI peptide vial affects insulin, cell cycle, and oxidative stress signalling